60 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
on a purchase order basis and do not have long-term committed supply arrangements with respect to our product candidates and other materials. Should any … are manufactured using reliable and reproducible synthetic processes from readily available starting materials and are based on chemistry that is amenable
DEFA14A
CCCC
C4 Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
8:04am
Additional Materials
Soliciting Material Pursuant to §240.14a12
C4 THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 011.
8-K
EX-10.1
efa24j31y06ux5avyh9
30 May 23
Entry into a Material Definitive Agreement
7:30am
ARS
fmol561l85jx 7g
28 Apr 23
Annual report to shareholders
7:03am
DEFA14A
l1a0o5j eycm
28 Apr 23
Additional proxy soliciting materials
7:02am
PRE 14A
a3z86bbh1f
18 Apr 23
Preliminary proxy
7:59am
DEFA14A
qw80dy
17 Jun 22
Additional proxy soliciting materials
4:06pm
DEFA14A
3en1r
12 May 22
Additional proxy soliciting materials
4:02pm